Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480)
7,870.00
-400.00 (-4.84%)
At close: Mar 31, 2026
KOSDAQ:036480 Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3,446 | 3,630 | 4,362 | 3,852 | 4,395 |
Short-Term Investments | 5,943 | 5,423 | 7,365 | 9,007 | 5,539 |
Cash & Short-Term Investments | 9,388 | 9,053 | 11,727 | 12,859 | 9,935 |
Cash Growth | 3.70% | -22.80% | -8.80% | 29.44% | -1.17% |
Accounts Receivable | 5,024 | 3,779 | 4,131 | 3,040 | 2,986 |
Other Receivables | 162.58 | 178.67 | 154.12 | 155.37 | 71.96 |
Receivables | 5,187 | 3,958 | 4,285 | 3,196 | 3,058 |
Inventory | 10,555 | 10,481 | 12,499 | 11,641 | 10,614 |
Prepaid Expenses | 97.17 | 106.25 | 171.07 | 35.26 | 32.9 |
Other Current Assets | 6.92 | 42.77 | 34.1 | 958.97 | 82.36 |
Total Current Assets | 25,234 | 23,641 | 28,717 | 28,690 | 23,722 |
Property, Plant & Equipment | 29,950 | 31,944 | 32,124 | 33,303 | 35,846 |
Long-Term Investments | 1,152 | 1,310 | 1,498 | 1,256 | 1,327 |
Other Intangible Assets | 354.51 | 354.8 | 356.77 | 354.83 | 356.3 |
Long-Term Deferred Tax Assets | 849.28 | 574.44 | 734.47 | 134.47 | 355.46 |
Long-Term Deferred Charges | 74.17 | 192.79 | 330.08 | 518.86 | 717.28 |
Other Long-Term Assets | 365.08 | 361.62 | 530.37 | 852.47 | 295.71 |
Total Assets | 57,979 | 58,379 | 64,290 | 65,109 | 62,620 |
Accounts Payable | 1,127 | 1,318 | 1,543 | 977.94 | 768.84 |
Accrued Expenses | 512.87 | 494.15 | 711.53 | 2,641 | 2,047 |
Short-Term Debt | 1,500 | 1,000 | 5,319 | 2,000 | 700 |
Current Portion of Long-Term Debt | 4,625 | 750 | 2,125 | 4,350 | 1,500 |
Current Portion of Leases | 223.73 | 257.16 | 152.28 | 140.83 | 175.61 |
Current Income Taxes Payable | - | - | - | 377.59 | - |
Other Current Liabilities | 542.94 | 710.73 | 547.67 | 124.03 | 122.82 |
Total Current Liabilities | 8,532 | 4,530 | 10,398 | 10,611 | 5,315 |
Long-Term Debt | 13,500 | 18,125 | 16,375 | 15,500 | 19,850 |
Long-Term Leases | 129.09 | 295.43 | 40.36 | 38.45 | 126.51 |
Pension & Post-Retirement Benefits | - | - | - | - | 194.65 |
Other Long-Term Liabilities | 397.04 | 279.04 | 127.98 | 122.51 | 130.67 |
Total Liabilities | 22,558 | 23,230 | 26,942 | 26,272 | 25,616 |
Common Stock | 1,900 | 1,900 | 1,900 | 1,900 | 1,900 |
Additional Paid-In Capital | 3,085 | 3,085 | 3,085 | 3,085 | 3,085 |
Retained Earnings | 27,277 | 27,005 | 29,204 | 30,693 | 28,859 |
Comprehensive Income & Other | 3,160 | 3,160 | 3,160 | 3,160 | 3,160 |
Shareholders' Equity | 35,421 | 35,149 | 37,349 | 38,837 | 37,004 |
Total Liabilities & Equity | 57,979 | 58,379 | 64,290 | 65,109 | 62,620 |
Total Debt | 19,978 | 20,428 | 24,011 | 22,029 | 22,352 |
Net Cash (Debt) | -10,589 | -11,374 | -12,284 | -9,170 | -12,418 |
Net Cash Per Share | - | -2993.19 | -3232.58 | -2413.27 | -3267.79 |
Filing Date Shares Outstanding | - | 3.8 | 3.8 | 3.8 | 3.8 |
Total Common Shares Outstanding | - | 3.8 | 3.8 | 3.8 | 3.8 |
Working Capital | 16,703 | 19,111 | 18,319 | 18,079 | 18,407 |
Book Value Per Share | - | 9249.83 | 9828.59 | 10220.37 | 9737.79 |
Tangible Book Value | 35,067 | 34,795 | 36,992 | 38,483 | 36,647 |
Tangible Book Value Per Share | - | 9156.47 | 9734.70 | 10127.00 | 9644.03 |
Land | 2,982 | 2,982 | 2,982 | 2,982 | 5,335 |
Buildings | 15,457 | 16,026 | 16,596 | 17,167 | 17,741 |
Machinery | 11,095 | 12,322 | 9,449 | 10,679 | 10,440 |
Construction In Progress | 74.35 | 74.35 | 2,909 | 2,302 | 2,038 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.